Endocrine control of benign prostatic hyperplasia

Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus

(2016) Harvey J. Murff et al.   Journal of Mens Health

The role of prolactin in andrology: what is new?

(2015) Giulia Rastrelli et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective

(2015) Hala H. Mosli et al.   Scientific Reports

Male accessory gland inflammation prevalence in type 2 diabetic patients with symptoms possibly reflecting autonomic neuropathy

(2014) Sandro La Vignera et al.   ASIAN JOURNAL OF ANDROLOGY

Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism

(2014) A. Lenzi et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Does prolactin induce apoptosis? Evidences in a prostate cancer in vitro model

(2014) D. Giuffrida et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation

(2014) P. Comeglio et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Androgen regulation of prostate cancer: Where are we now?

(2014) G. Corona et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk

(2014) Xian-Tao Zeng et al.   MOLECULAR BIOLOGY REPORTS

Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia

(2014) Rui Shao et al.   PROSTATE

Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions

(2014) Giovanni Corona et al.   International Journal of Endocrinology

Benign prostatic hyperplasia: a new metabolic disease?

(2014) L. Vignozzi et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk

(2013) S-C Hung et al.   BRITISH JOURNAL OF CANCER

Stromal Insulin-Like Growth Factor Binding Protein 3 (IGFBP3) Is Elevated in the Diseased Human Prostate and Promotes ex Vivo Fibroblast-to-Myofibroblast Differentiation

(2013) Natalie Sampson et al.   ENDOCRINOLOGY

Serum PSA as a Predictor of Testosterone Deficiency

(2013) Giulia Rastrelli et al.   Journal of Sexual Medicine

Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia

(2013) Mohammad-Ali Haghsheno et al.   JOURNAL OF UROLOGY

Targeting Stromal Androgen Receptor Suppresses Prolactin-Driven Benign Prostatic Hyperplasia (BPH)

(2013) Kuo-Pao Lai et al.   MOLECULAR ENDOCRINOLOGY

Role of 5α-reductase inhibitors in benign prostatic diseases

(2012) F Azzouni et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Chemokines and BPH/LUTS

(2011) Jill A. Macoska   DIFFERENTIATION

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

(2011) Tristan M. Nicholson et al.   DIFFERENTIATION

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

(2011) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue

(2011) Dieter Mitteregger et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Suppressed Prostate Epithelial Development with Impaired Branching Morphogenesis in Mice Lacking Stromal Fibromuscular Androgen Receptor

(2011) Kuo-Pao Lai et al.   MOLECULAR ENDOCRINOLOGY

Prolactin regulation of the prostate gland: a female player in a male game

(2011) Vincent Goffin et al.   Nature Reviews Urology

Estrogen and androgen signaling in the pathogenesis of BPH

(2011) Clement K. M. Ho et al.   Nature Reviews Urology

Body mass index and risk of BPH: a meta-analysis

(2011) S Wang et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study

(2010) Kazuyoshi Shigehara et al.   Aging Male

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia

(2010) Luciano Adorini et al.   Annals of the New York Academy of Sciences

Benign prostate hyperplasia: a review of the yearʼs progress from bench to clinic

(2010) Robert F Donnell   CURRENT OPINION IN UROLOGY

Estrogen receptor-  activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF  mediated

(2010) S. J. McPherson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells

(2010) Shengqiang Yu et al.   PROSTATE

Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men

(2009) P. Abrams et al.   JOURNAL OF UROLOGY

Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth

(2008) Abraham Morgentaler et al.   EUROPEAN UROLOGY

Pathology of benign prostatic hyperplasia

(2008) C G Roehrborn   INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH

Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen

(2008) Clement K M Ho et al.   JOURNAL OF ENDOCRINOLOGY

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

(2008) J Hammarsten et al.   PROSTATE CANCER AND PROSTATIC DISEASES